Engineering a Human P2X2 Receptor with Altered Ligand Selectivity in Yeast.

Ligand-gated ion channels P2X2 protein engineering yeast humanization

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
29 Mar 2024
Historique:
received: 29 05 2023
revised: 14 03 2024
accepted: 23 03 2024
medline: 1 4 2024
pubmed: 1 4 2024
entrez: 31 3 2024
Statut: aheadofprint

Résumé

P2X receptors are a family of ligand gated ion channels found in a range of eukaryotic species including humans but are not naturally present in the yeast Saccharomyces cerevisiae. We demonstrate the first recombinant expression and functional gating of the P2X2 receptor in baker's yeast. We leverage the yeast host for facile genetic screens of mutant P2X2 by performing site saturation mutagenesis at residues of interest, including SNPs implicated in deafness and at residues involved in native binding. Deep mutational analysis and rounds of genetic engineering yield mutant P2X2 F303Y A304W, which has altered ligand selectivity towards the ATP analog AMP-PNP. The F303Y A304 variant shows over 100-fold increased intracellular calcium amplitudes with AMP-PNP compared to the WT receptor and has a much lower desensitization rate. Since AMP-PNP does not naturally activate P2X receptors, the F303Y A304 P2X2 may be a starting point for downstream applications in chemogenetic cellular control. Interestingly, the A304W mutation selectively destabilizes the desensitized state, which may provide a mechanistic basis for receptor opening with suboptimal agonists. The yeast system represents an inexpensive, scalable platform for ion channel characterization and engineering by circumventing the more expensive and time-consuming methodologies involving mammalian hosts.

Identifiants

pubmed: 38556082
pii: S0021-9258(24)01745-9
doi: 10.1016/j.jbc.2024.107248
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107248

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Elizabeth C Gardner (EC)

Department of Molecular Biosciences, Center for Systems and Synthetic Biology, The University of Texas at Austin, Austin, TX 78712 USA.

Caitlin Tramont (C)

Department of Molecular Biosciences, Center for Systems and Synthetic Biology, The University of Texas at Austin, Austin, TX 78712 USA.

Petra Bachanová (P)

Department of Molecular Biosciences, Center for Systems and Synthetic Biology, The University of Texas at Austin, Austin, TX 78712 USA.

Chad Wang (C)

Department of Molecular Biosciences, Center for Systems and Synthetic Biology, The University of Texas at Austin, Austin, TX 78712 USA.

Hannah Do (H)

Department of Molecular Biosciences, Center for Systems and Synthetic Biology, The University of Texas at Austin, Austin, TX 78712 USA.

Daniel R Boutz (DR)

Antibody Discovery and Accelerated Protein Therapeutics, Deppartment of Pathology & Genomic Medicine, Houston Methodist Research Institute, Houston, TX 77030 USA.

Shaunak Kar (S)

Antibody Discovery and Accelerated Protein Therapeutics, Deppartment of Pathology & Genomic Medicine, Houston Methodist Research Institute, Houston, TX 77030 USA.

Boris V Zemelman (BV)

Center for Learning and Memory, Department of Neuroscience, The University of Texas at Austin, Austin, TX, USA. Electronic address: zemelmanb@mail.clm.utexas.edu.

Jimmy D Gollihar (JD)

Antibody Discovery and Accelerated Protein Therapeutics, Deppartment of Pathology & Genomic Medicine, Houston Methodist Research Institute, Houston, TX 77030 USA. Electronic address: jgollihar2@houstonmethodist.org.

Andrew D Ellington (AD)

Department of Molecular Biosciences, Center for Systems and Synthetic Biology, The University of Texas at Austin, Austin, TX 78712 USA. Electronic address: ellingtonlab@gmail.com.

Classifications MeSH